229 related articles for article (PubMed ID: 16778096)
41. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F
Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961
[TBL] [Abstract][Full Text] [Related]
42. Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin.
Starenki DV; Namba H; Saenko VA; Ohtsuru A; Maeda S; Umezawa K; Yamashita S
Clin Cancer Res; 2004 Oct; 10(20):6821-9. PubMed ID: 15501958
[TBL] [Abstract][Full Text] [Related]
43. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
44. SBDS-deficiency results in specific hypersensitivity to Fas stimulation and accumulation of Fas at the plasma membrane.
Watanabe K; Ambekar C; Wang H; Ciccolini A; Schimmer AD; Dror Y
Apoptosis; 2009 Jan; 14(1):77-89. PubMed ID: 19009351
[TBL] [Abstract][Full Text] [Related]
45. Fraxetin inhibits the induction of anti-Fas IgM, tumor necrosis factor-alpha and interleukin-1beta-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63.
Kuo PL; Huang YT; Chang CH; Chang JK
Int Immunopharmacol; 2006 Jul; 6(7):1167-75. PubMed ID: 16714221
[TBL] [Abstract][Full Text] [Related]
46. Interferon-gamma and tumor necrosis factor-alpha sensitize primarily resistant human endometrial stromal cells to Fas-mediated apoptosis.
Fluhr H; Krenzer S; Stein GM; Stork B; Deperschmidt M; Wallwiener D; Wesselborg S; Zygmunt M; Licht P
J Cell Sci; 2007 Dec; 120(Pt 23):4126-33. PubMed ID: 18003704
[TBL] [Abstract][Full Text] [Related]
47. A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis.
Monteleone I; Monteleone G; Fina D; Caruso R; Petruzziello C; Calabrese E; Biancone L; Pallone F
Gastroenterology; 2006 Feb; 130(2):389-97. PubMed ID: 16472594
[TBL] [Abstract][Full Text] [Related]
48. Myricetin inhibits the induction of anti-Fas IgM-, tumor necrosis factor-alpha- and interleukin-1beta-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63.
Kuo PL
Life Sci; 2005 Oct; 77(23):2964-76. PubMed ID: 15982670
[TBL] [Abstract][Full Text] [Related]
49. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
[TBL] [Abstract][Full Text] [Related]
50. C/EBPbeta associates with caspase 8 complex proteins and modulates apoptosis in hepatic stellate cells.
Buck M; Chojkier M
J Clin Gastroenterol; 2007; 41 Suppl 3():S295-9. PubMed ID: 17975479
[TBL] [Abstract][Full Text] [Related]
51. Viral FLIP enhances Wnt signaling downstream of stabilized beta-catenin, leading to control of cell growth.
Nakagiri S; Murakami A; Takada S; Akiyama T; Yonehara S
Mol Cell Biol; 2005 Nov; 25(21):9249-58. PubMed ID: 16227577
[TBL] [Abstract][Full Text] [Related]
52. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY
Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429
[TBL] [Abstract][Full Text] [Related]
53. Proteasome inhibition blocks caspase-8 degradation and sensitizes prostate cancer cells to death receptor-mediated apoptosis.
Thorpe JA; Christian PA; Schwarze SR
Prostate; 2008 Feb; 68(2):200-9. PubMed ID: 18076022
[TBL] [Abstract][Full Text] [Related]
54. TCR engagement regulates differential responsiveness of human memory T cells to Fas (CD95)-mediated apoptosis.
Di Somma MM; Somma F; Gilardini Montani MS; Mangiacasale R; Cundari E; Piccolella E
J Immunol; 1999 Apr; 162(7):3851-8. PubMed ID: 10201902
[TBL] [Abstract][Full Text] [Related]
55. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
[TBL] [Abstract][Full Text] [Related]
56. BCL-XL regulates TNF-alpha-mediated cell death independently of NF-kappaB, FLIP and IAPs.
Gozzelino R; Sole C; Llecha N; Segura MF; Moubarak RS; Iglesias-Guimarais V; Perez-Garcia MJ; Reix S; Zhang J; Badiola N; Sanchis D; Rodriguez-Alvarez J; Trullas R; Yuste VJ; Comella JX
Cell Res; 2008 Oct; 18(10):1020-36. PubMed ID: 18591962
[TBL] [Abstract][Full Text] [Related]
57. Fas ligand-induced apoptosis is regulated by nitric oxide through the inhibition of fas receptor clustering and the nitrosylation of protein kinase Cepsilon.
Dash PR; McCormick J; Thomson MJ; Johnstone AP; Cartwright JE; Whitley GS
Exp Cell Res; 2007 Oct; 313(16):3421-31. PubMed ID: 17761163
[TBL] [Abstract][Full Text] [Related]
58. c-FLICE inhibitory protein expression inhibits T-cell activation.
Tai TS; Fang LW; Lai MZ
Cell Death Differ; 2004 Jan; 11(1):69-79. PubMed ID: 12970675
[TBL] [Abstract][Full Text] [Related]
59. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R
Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826
[TBL] [Abstract][Full Text] [Related]
60. Fas (CD95) ligation inhibits activation of NF-kappa B by targeting p65-Rel A in a caspase-dependent manner.
Wong HK; Tsokos GC
Clin Immunol; 2006 Oct; 121(1):47-53. PubMed ID: 16765090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
